Treatment of Superior Sagittal Sinus Thrombosis

Diagnostic Approach

Diagnosis should be confirmed with MRI/MRV or CT/CTV before initiating treatment, as recommended by the American Heart Association 1, 2
MRV techniques (time-of-flight or contrast-enhanced) are preferred for visualizing venous structures and confirming thrombosis, according to the American Heart Association 2
Imaging should include evaluation for secondary signs such as cerebral swelling, edema, and/or hemorrhage, as suggested by the American Heart Association 2

The American College of Chest Physicians recommends beginning therapeutic anticoagulation immediately upon diagnosis, with low molecular weight heparin (LMWH) or unfractionated heparin (UFH) as initial treatment options 1, 3
Anticoagulation should be continued for at least the first 3 months (treatment phase), as recommended by the American College of Chest Physicians 3
Anticoagulation is recommended even in the presence of intracranial hemorrhage, as the benefits of preventing thrombus progression outweigh bleeding risks, according to the American Heart Association 1, 2

The American College of Chest Physicians recommends against using direct oral anticoagulants (DOACs) for cerebral venous thrombosis, and instead suggests adjusted-dose vitamin K antagonists (target INR 2.5) as preferred treatment 3
For the initial treatment phase, LMWH is preferred over vitamin K antagonists, as recommended by the American College of Chest Physicians and the International Society on Thrombosis and Haemostasis 3, 4

Monitoring for signs of increased intracranial pressure is crucial, and may require additional interventions such as osmotic therapy (mannitol or hypertonic saline), as suggested by the Congress of Neurological Surgeons 5
In cases of deterioration despite medical therapy, surgical decompression with hematoma evacuation may be necessary, according to the Congress of Neurological Surgeons 5, 6

In patients who develop intracranial hemorrhage while on anticoagulation, temporary discontinuation of anticoagulation may be necessary, but anticoagulation should be resumed once stabilized, as recommended by the American Heart Association 1, 5

Regular neurological assessment is essential to detect early signs of deterioration, as suggested by the Congress of Neurological Surgeons 5
Follow-up imaging (MRV or CTV) should be performed to assess recanalization, as recommended by the American Heart Association 2
Monitoring for signs of post-thrombotic syndrome is necessary, and may require additional interventions, as suggested by the American College of Chest Physicians 3

Delaying anticoagulation due to fear of hemorrhagic complications can lead to thrombus progression and worse outcomes, as warned by the American Heart Association 1
Misdiagnosis is common, and headache may be mistaken for migraine, leading to delayed treatment, as noted by the Congress of Neurological Surgeons 5
The American College of Chest Physicians advises against using DOACs as first-line therapy, as evidence for their efficacy in cerebral venous thrombosis is limited 3